DK1285667T3 - Farmaceutisk injicerbar oplösning af paracetamol og kombinationer af paracetamol med andre aktive bestanddele - Google Patents

Farmaceutisk injicerbar oplösning af paracetamol og kombinationer af paracetamol med andre aktive bestanddele

Info

Publication number
DK1285667T3
DK1285667T3 DK02023125T DK02023125T DK1285667T3 DK 1285667 T3 DK1285667 T3 DK 1285667T3 DK 02023125 T DK02023125 T DK 02023125T DK 02023125 T DK02023125 T DK 02023125T DK 1285667 T3 DK1285667 T3 DK 1285667T3
Authority
DK
Denmark
Prior art keywords
paracetamol
combinations
active ingredients
injectable solution
glycerol formal
Prior art date
Application number
DK02023125T
Other languages
English (en)
Inventor
Julia Tsetis
Original Assignee
Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8230107&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1285667(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa filed Critical Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa
Application granted granted Critical
Publication of DK1285667T3 publication Critical patent/DK1285667T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK02023125T 1997-11-18 1997-11-18 Farmaceutisk injicerbar oplösning af paracetamol og kombinationer af paracetamol med andre aktive bestanddele DK1285667T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97600009A EP0916347B1 (en) 1997-11-18 1997-11-18 Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances

Publications (1)

Publication Number Publication Date
DK1285667T3 true DK1285667T3 (da) 2006-09-11

Family

ID=8230107

Family Applications (2)

Application Number Title Priority Date Filing Date
DK97600009T DK0916347T3 (da) 1997-11-18 1997-11-18 Farmaceutiske injicerbare opløsninger der indeholder paracetamol og kombinationer af paracetamol med andre aktive bestanddele
DK02023125T DK1285667T3 (da) 1997-11-18 1997-11-18 Farmaceutisk injicerbar oplösning af paracetamol og kombinationer af paracetamol med andre aktive bestanddele

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK97600009T DK0916347T3 (da) 1997-11-18 1997-11-18 Farmaceutiske injicerbare opløsninger der indeholder paracetamol og kombinationer af paracetamol med andre aktive bestanddele

Country Status (9)

Country Link
EP (2) EP1285667B1 (da)
AT (2) ATE329621T1 (da)
CY (1) CY2562B1 (da)
DE (2) DE69736140T2 (da)
DK (2) DK0916347T3 (da)
ES (2) ES2265470T3 (da)
HK (1) HK1020866A1 (da)
PT (2) PT916347E (da)
SI (2) SI0916347T1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1003969B (el) * 2001-02-05 2002-08-14 U��-Pharma ����� ������ ������������ ���������� ���� Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης.
DE10112325A1 (de) * 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
HUP0402549A3 (en) * 2001-12-18 2006-01-30 Tseti Ioulia Parenteral composition of paracetamol
FR2851164B1 (fr) * 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
DE102005037653A1 (de) 2005-08-05 2007-02-15 Theraselect Gmbh Stabile, flüssige Formulierung von Paracetamol
AU2006346318B2 (en) * 2006-07-18 2011-02-10 Genfarma Laboratorio S.L. Injectable liquid paracetamol formulation
WO2009098716A2 (en) * 2008-01-17 2009-08-13 Aptuit Laurus Private Limited Stable pharmaceutical aqueous compositions
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US8404748B2 (en) 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
EP2464332B1 (en) 2009-08-13 2016-03-02 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
DK2588097T3 (da) 2010-06-30 2021-05-10 Troikaa Pharmaceuticals Ltd Farmaceutiske sammensætninger omfattende paracetamol og fremgangsmåde til fremstilling af samme
JO3400B1 (ar) 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
CN103476395A (zh) 2011-02-10 2013-12-25 尼奥根公司 在水溶液中贮存稳定的扑热息痛制剂
AU2012225268B2 (en) 2011-03-10 2016-10-20 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of peptide drugs
ES2574761T3 (es) 2011-10-31 2016-06-21 Xeris Pharmaceuticals, Inc. Formulaciones para el tratamiento de la diabetes
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
AU2015300944B2 (en) 2014-08-06 2019-07-11 Xeris Pharmaceuticals, Inc. Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
AU2018275686B2 (en) 2017-06-02 2024-02-01 Xeris Pharmaceuticals, Inc. Precipitation resistant small molecule drug formulations
GB201811858D0 (en) * 2018-07-20 2018-09-05 Wockhardt Uk Ltd Liquid pharmaceutical composition for oral administration comprising paracetamol and codeine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3111591A1 (de) * 1981-03-24 1982-10-14 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Blutdrucksenkendes arzneimittel
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
GR1001523B (el) * 1991-07-04 1994-01-28 Uni Pharma Tsetis Kleon Farmak Ενέσιμα διαλύματα του συνδυασμού παρακεταμόλης και κωδεϊνης.
NZ248486A (en) * 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
GR1002731B (el) * 1996-10-21 1997-07-04 Uni-Pharma ����� ������ �.�.�.�. ������������ ���������� Φαρμακευτικα ενεσιμα διαλυματα περιεχοντα συνδυασμους παρακεταμολης με αλλες δραστικες ουσιες.

Also Published As

Publication number Publication date
EP1285667A3 (en) 2003-03-26
ATE232741T1 (de) 2003-03-15
DE69736140D1 (de) 2006-07-27
HK1020866A1 (en) 2000-05-26
DK0916347T3 (da) 2003-04-22
PT916347E (pt) 2003-07-31
CY2562B1 (en) 2008-07-02
ATE329621T1 (de) 2006-07-15
ES2265470T3 (es) 2007-02-16
ES2192256T3 (es) 2003-10-01
EP1285667A2 (en) 2003-02-26
PT1285667E (pt) 2006-11-30
EP0916347B1 (en) 2003-02-19
DE69719189D1 (de) 2003-03-27
EP0916347A1 (en) 1999-05-19
SI0916347T1 (en) 2003-06-30
DE69736140T2 (de) 2007-04-19
EP1285667B1 (en) 2006-06-14
SI1285667T1 (sl) 2006-10-31
DE69719189T2 (de) 2003-11-27

Similar Documents

Publication Publication Date Title
DK1285667T3 (da) Farmaceutisk injicerbar oplösning af paracetamol og kombinationer af paracetamol med andre aktive bestanddele
ATE345757T1 (de) Verabreichung eines arzneistoffs mittels einer sich-phasenumwandelnden formulierung
AR011846A1 (es) Una composicion farmaceutica, y el procedimiento para prepararla
ES2094694B1 (es) Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
AR005281A1 (es) Composicion farceutica oral , procedimientos para su manufactura y uso de esa composicion farmaceutica para la preparacion de medicamentos. .
DK383987A (da) Ny galeniske formuleringer med programmeret afgivelse indeholdende antiphlogistika
SE8304003D0 (sv) Medicinsk komposition innehallande pirprofen
YU46012B (sh) Postupak za izradu vodenih gelirajućih rastvora derivata arilpropionske kiseline koji mogu da se resporbuju kroz kožu
DE69105040D1 (de) Arzneimittel gegen Impotenz.
NO991731D0 (no) Lokalanestetikum for utvortes bruk
ATE96329T1 (de) Topisch anwendbare pharmazeutische zubereitung.
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
ATE15596T1 (de) Pharmazeutische mittel.
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
ES2109131B1 (es) Composicion farmaceutica que tiene actividad analgesica.
YU107692A (sh) Sulfonamidi i postupak za njihovo dobijanje
FI863192A0 (fi) Preparat foer intramuskulaer injektering av mediciner, vitaminer eller vaccin.
DK0711163T3 (da) Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
RU2000110676A (ru) Способ консервативного лечения стриктур уретры
IT1270996B (it) Derivati fosforilati di composti aventi attivita' antiinfiammatoria o analgesica e procedimento per la loro preparazione
EA200000168A1 (ru) Фармацевтическая композиция, снижающая продуцирование белка мср-1
KR927003530A (ko) 이온삼투요법용 제약 제제의 제조에 있어서의 국소 마취제의 용도
DE69716485T2 (de) Taxol enthaltende pharmazeutische injektionslösung
ES2131331T3 (es) Uso de benzotiofenos para la preparacion de un medicamento para reducir la formacion de cicatrices en la curacion de heridas.